Clara Moriano

Leon, CL, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Major adverse cardiovascular events in Sjögren's disease: incidence, associated factors, and impact on mortality in a prospective multicenter cohort.

Major adverse cardiovascular events in Sjögren's disease: incidence, associated factors, and impact on mortality in a prospective multicenter cohort.

Journal: Rheumatology international

Published: March 05, 2026

Spanish multicenter registry of belimumab in systemic lupus erythematosus: Data from daily clinical practice.

Spanish multicenter registry of belimumab in systemic lupus erythematosus: Data from daily clinical practice.

Journal: Seminars in arthritis and rheumatism

Published: December 23, 2025

Real-world experience with belimumab-based triple therapy in proliferative lupus nephritis: data from the BEL-SPAIN Registry.

Real-world experience with belimumab-based triple therapy in proliferative lupus nephritis: data from the BEL-SPAIN Registry.

Journal: Lupus science & medicine

Published: September 25, 2025

Nervous system involvement in primary Sjögren's syndrome: analysis from the Sjögrenser registry.

Nervous system involvement in primary Sjögren's syndrome: analysis from the Sjögrenser registry.

Journal: Modern rheumatology

Published: September 18, 2025

Can Vitamin D Reduce Glucocorticoid-Induced Adverse Effects in Patients with Giant Cell Arteritis? Results from 1568 Patients in the Spanish ARTESER Registry.

Can Vitamin D Reduce Glucocorticoid-Induced Adverse Effects in Patients with Giant Cell Arteritis? Results from 1568 Patients in the Spanish ARTESER Registry.

Journal: Nutrients

Published: September 08, 2025

Sex differences among patients with giant cell arteritis: insights from the Spanish ARTESER Registry.

Sex differences among patients with giant cell arteritis: insights from the Spanish ARTESER Registry.

Journal: Rheumatology (Oxford, England)

Published: July 14, 2025

High incidence of lymphoma in Sjögren's disease: predictors and mortality implications in a prospective cohort study.

High incidence of lymphoma in Sjögren's disease: predictors and mortality implications in a prospective cohort study.

Journal: Rheumatology international

Published: May 28, 2025

Cancer risk in Sjögren's disease: A longitudinal cohort study on incidence, predictors, and mortality impact.

Cancer risk in Sjögren's disease: A longitudinal cohort study on incidence, predictors, and mortality impact.

Journal: Seminars in arthritis and rheumatism

Published: March 12, 2025

Long-term changes in Sjögren's disease: a 9-year prospective follow-up study from the SJOGRENSER Registry.

Long-term changes in Sjögren's disease: a 9-year prospective follow-up study from the SJOGRENSER Registry.

Journal: Rheumatology international

Published: March 08, 2025

Epidemiology of major and minor relapses in giant cell arteritis according to EULAR definitions: insights from the ARTESER registry.

Epidemiology of major and minor relapses in giant cell arteritis according to EULAR definitions: insights from the ARTESER registry.

Journal: Rheumatology (Oxford, England)

Published: January 05, 2025

Mortality in Patients With Sjögren Disease: A Prospective Cohort Study Identifying Key Predictors.

Mortality in Patients With Sjögren Disease: A Prospective Cohort Study Identifying Key Predictors.

Journal: The Journal of rheumatology

Published: December 09, 2024

Can the dose of belimumab be reduced in patients with systemic lupus erythematosus?

Can the dose of belimumab be reduced in patients with systemic lupus erythematosus?

Journal: Rheumatology (Oxford, England)

Published: January 16, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026